Christopher Brett Primiano, EVP, CBO, GC & Secretary at Karyopharm Therapeutics Inc. (KPTI), sold 2,500 shares at $15.02 ($38K) on 2018-02-15, disclosed to the SEC on 2018-02-20.
Scheduled sale ($38k) by EVP, CBO, GC & Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.02 | 1,014 | $15K | 40.6% |
| 2 | $15.01 | 1,486 | $22K | 59.4% |
| Total | $15.01 avg | 2,500 | $38K | 100% |
| Filing → |
| KPTI | SELL | 2020-10-14 | $1.3M | — | Filing → |
| KPTI | SELL | 2020-09-10 | $301K | — | Filing → |
| KPTI | SELL | 2020-05-11 | $322K | — | Filing → |